• Science and Research

  CF Therapy Candidate Granted Orphan Status in Europe

  Posted by Cystic Fibrosis News Moderator on April 17, 2019 at 7:11 pm

  In the European Union, Synspira’s cystic fibrosis therapeutic candidate, SNSP113, has been designated as an orphan drug by EMA. Click here to read more about this decision.

  What do you think of this news?

  Cystic Fibrosis News Moderator replied 6 years, 2 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply